Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have stated that they take no responsibility for the contents of the recent announcement by China NT Pharma Group Company Limited (the “Company”) and disclaim liability for any potential losses arising from reliance on it.

According to the Company, trading in its shares was halted on 10 February 2026 at 9:03 a.m. The decision was made following the need to release additional information related to the Company’s announcement on 9 February 2026, concerning the issuance of convertible bonds under a general mandate.

The Company’s Board of Directors comprises two executive directors, two non-executive directors, and three independent non-executive directors. They include Chairman and Executive Director Mr. Ng Tit, alongside Executive Director Ms. Ng Anna Ching Mei, Non-Executive Directors Dr. Qian Wei and Ms. Chin Yu, and Independent Non-Executive Directors Mr. Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Mr. Ng Ming Kwan.